查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球维生素 K2 市场：按功能、产品类型、申请形式、原产地、应用、地区 - 预测至 2029 年
市场调查报告书
商品编码
1504304

全球维生素 K2 市场：按功能、产品类型、申请形式、原产地、应用、地区 - 预测至 2029 年

Vitamin K2 Market by Product Type, Source, Form, Application, Function - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 228 Pages | 订单完成后即时交付

价格
简介目录

预计2024年全球维生素K2市场规模为1.4亿美元，复合年增长率预估为13.7%，2029年达2.65亿美元。

维生素 K2 市场的成长是由研发进步所推动的。正在进行的研究不断发现维生素 K2 新的健康益处和潜在用途，从而扩大了其吸引力。这些新的好处服务于更广泛的消费者群体，并为食品和机能性食品领域的产品创新创造新的机会。

调查范围
调查年份 2024-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（美元）
按细分市场 按功能、产品类型、申请形式、原产地、应用、地区
目标区域 北美、欧洲、亚太等地区

此外，市场成长是由消费者意识和教育的提高所推动的。卫生组织和补充品製造商提供的宣传活动和资讯资源显着提高了人们对维生素 K2 重要性的认识。这增强了消费者的信心并增加了维生素 K2 强化产品的消费。此外，个人化营养的趋势，即消费者寻求量身定制的营养解决方案来满足其特定的健康需求，正在加速对维生素 K2补充品的需求。

这一趋势主要是由于消费者对预防性医疗保健和健康的偏好不断增加而推动的。随着人们越来越认识到维持骨骼和心血管健康的长期益处，对有效且可靠的补充品的需求激增。维生素 K2 以其在钙代谢和心血管保护中的重要作用而闻名，在註重健康的消费者中广受欢迎。

膳食食品产业占据主导地位的主要原因之一是越来越多的科学证据支持维生素 K2 的有效性。大量研究强调了维生素 K2 透过提高骨骼密度和防止动脉钙化来降低骨质疏鬆症和心血管疾病风险的作用。这些好处对于更容易感染这些疾病的老年人来说尤其有吸引力。因此，维生素 K2补充品已成为寻求改善健康和生活品质的老年人的热门选择。

本报告检视了全球维生素 K2 市场，并按功能、产品类型、应用形式、原产地、用途、地区和进入市场的公司概况总结了趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 宏观经济指标
  • 市场动态

第六章 产业趋势

  • 介绍
  • 供应链分析
  • 价值链分析
  • 贸易分析
  • 技术分析
  • 价格分析
  • 生态系分析
  • 影响客户业务的趋势/干扰
  • 专利分析
  • 2024-2025年重大会议和活动
  • 监管状况
  • 波特五力分析
  • 主要相关人员和采购标准
  • 案例研究分析
  • 投资金筹措场景

第七章维生素K2市场（依功能）

  • 介绍
  • 骨骼和心血管健康
  • 血液健康和凝血
  • 发炎和免疫
  • 其他的

第八章维生素K2市场（依产品类型）

  • 介绍
  • MK-4
  • MK-7

第九章维生素K2市场（依申请表）

  • 介绍
  • 胶囊和锭剂
  • 粉末和结晶
  • 液体

第10章维生素K2市场（按产地）

  • 介绍
  • 自然的
  • 合成

第十一章维生素K2市场（依应用）

  • 介绍
  • 药品
  • 机能性食品和饮料
  • 保健补充品

第十二章维生素K2市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第十三章竞争格局

  • 概述
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业价值评估及财务指标
  • 品牌/产品比较分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 竞争格局及趋势

第十四章 公司简介

  • 主要参与企业
    • GNOSIS BY LESAFFRE（NATTOPHARMA）
    • KAPPA BIOSCIENCE AS（BALCHEM CORP.）
    • J-OIL MILLS, INC.
    • NOVOZYMES A/S
    • BASF SE
    • SUNGEN BIOSCIENCE CO.,LTD
    • VESTA NUTRA
    • RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
    • MENADIONA
    • GENOFOCUS
    • ANGELYEAST CO., LTD.
    • GENEFERM BIOTECHNOLOGY CO., LTD.
    • NAKODA CHEMICALS LTD.
    • HAIHANG INDUSTRY
    • CHEMICEA LIMITED
    • KYOWA HAKKO USA, INC.
  • Start-Ups/小型企业
    • SEEBIO BIOTECH（SHANGHAI）CO.,LTD.
    • MAGNESIA GMBH
    • FALCON TRADING INTERNATIONAL
    • ABCO INDIA
    • ACT

第十五章 邻近及相关市场

第十六章附录

简介目录
Product Code: FB 9049

The global vitamin K2 market is estimated to be valued at USD 140 million in 2024 and is projected to reach USD 265 million by 2029 at a CAGR of 13.7%. The growth of the Vitamin K2 market is propelled by advancements in research and development. Ongoing studies continue to uncover new health benefits and potential applications for Vitamin K2, thereby expanding its appeal. These emerging benefits contribute to a broader consumer base and create new opportunities for product innovation in the nutraceutical and functional food sectors.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product Type, Source, Form, Application, Function & Region
Regions coveredNorth America, Europe, Asia Pacific, and Rest of the World

Furthermore, market growth is facilitated by increasing consumer awareness and education. Campaigns and informational resources provided by health organizations and supplement manufacturers have significantly raised awareness about the importance of Vitamin K2. This has led to higher consumer confidence and an uptick in the consumption of Vitamin K2-enriched products. Additionally, the trend towards personalized nutrition, where consumers seek tailored dietary solutions to meet their specific health needs, has spurred demand for Vitamin K2 supplements.

"During the forecast period, the health supplements segment in applications emerges as the dominant segment in the vitamin K2 market."

This trend is largely driven by the increasing consumer inclination towards preventive healthcare and wellness. As individuals become more aware of the long-term benefits of maintaining bone and cardiovascular health, the demand for effective and reliable supplements has surged. Vitamin K2, known for its crucial role in calcium metabolism and cardiovascular protection, is gaining significant traction among health-conscious consumers.

One of the primary reasons for the dominance of the health supplements segment is the growing body of scientific evidence supporting the efficacy of Vitamin K2. Numerous studies have highlighted its role in promoting bone density and preventing arterial calcification, thereby reducing the risk of osteoporosis and cardiovascular diseases. These benefits are particularly appealing to aging populations, who are more susceptible to these conditions. As a result, Vitamin K2 supplements have become a popular choice among older adults looking to enhance their health and quality of life.

"Powder & Crystalline form is the dominant market in the vitamin K2 market."

The powder & crystalline form of Vitamin K2 is emerging as the dominant segment in the Vitamin K2 market, driven by its versatile applications and numerous advantages over other forms. This trend reflects a growing preference for powdered supplements in both the consumer and industrial markets, underscoring the convenience, stability, and efficacy that powdered Vitamin K2 offers.

The factor contributing to the dominance of the powder form in the Vitamin K2 market is its exceptional versatility. Vitamin K2 powder can be easily incorporated into a wide range of products, including dietary supplements, functional foods, and beverages. This adaptability allows manufacturers to create a diverse array of Vitamin K2-enriched products, catering to various consumer preferences and dietary needs. For example, powdered Vitamin K2 can be seamlessly blended into protein shakes, nutritional bars, dairy products, and even baked goods, making it a suitable choice for both health enthusiasts and the general population.

The break-up of the profile of primary participants in the vitamin K2 market:

  • By Company Type: Tier 1 - 35%, Tier 2 - 30%, and Tier 3 - 35%
  • By Designation: C Level - 22%, Director Level - 33%, Others - 45%
  • By Region: North America - 17%, Europe - 26%, Asia Pacific - 38%, and Rest of the World - 19%

Prominent companies include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea) among others.

Research Coverage:

This research report categorizes the vitamin K2 market by Product Type (MK-4, MK-7), Source (Natural, Synthetic), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceuticals, Functional Food & Beverages, Health Supplements), and Region (North America, Europe, Asia Pacific, and Rest of the World).

The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the vitamin K2 market. It also provides a detailed analysis of the major players in the market, including their business overview, products offered, key strategies, partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the vitamin K2 market is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall vitamin K2 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growth in health consciousness among consumers and increasing health expenditure, and Increase in research and application of vitamin K2), restraints (Inconsistency in regulatory norms governing vitamin K2, and Price volatility of raw materials), opportunities (Growing demand for natural and functional foods, Demand for personalized nutrition and tailored menaquinone products, and Untapped vitamin K2 applications), and challenges (Lack of consumer awareness regarding benefits specific to vitamin K2, and High research and development costs) influencing the growth of the vitamin K2 market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the vitamin K2 market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the vitamin K2 market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin K2 market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea), among others in the vitamin K2 market strategies. The report also helps stakeholders understand the vitamin K2 market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 UNIT CONSIDERED
    • 1.4.1 CURRENCY UNIT
    • TABLE 2 USD EXCHANGE RATES, 2020-2023
    • 1.4.2 VOLUME UNIT
  • 1.5 STAKEHOLDERS
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 VITAMIN K2 MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key insights from industry experts
      • 2.1.2.3 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOP-DOWN APPROACH
    • FIGURE 2 VITAMIN K2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • 2.2.2 SUPPLY-SIDE ANALYSIS
    • FIGURE 3 VITAMIN K2 MARKET SIZE CALCULATION: SUPPLY-SIDE ANALYSIS
    • 2.2.3 BOTTOM-UP APPROACH
    • FIGURE 4 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS AND RISK ASSESSMENT
  • 2.6 RECESSION IMPACT ANALYSIS
    • 2.6.1 RECESSION MACROINDICATORS
    • FIGURE 6 INDICATORS OF RECESSION
    • FIGURE 7 GLOBAL INFLATION RATE, 2012-2022
    • FIGURE 8 GLOBAL GROSS DOMESTIC PRODUCT, 2012-2022 (USD TRILLION)
    • FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON VITAMIN K2 MARKET
    • FIGURE 10 GLOBAL VITAMIN K2 MARKET: CURRENT FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

    • TABLE 3 VITAMIN K2 MARKET SNAPSHOT, 2024 VS. 2029
    • FIGURE 11 MK-7 SEGMENT TO HOLD LARGER MARKET SIZE IN 2024
    • FIGURE 12 POWDER AND CRYSTALLINE TO BE LARGEST APPLICATION FORM SEGMENT IN 2024
    • FIGURE 13 NATURAL SOURCE SEGMENT TO DOMINATE MARKET IN 2024
    • FIGURE 14 PHARMACEUTICALS APPLICATION SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
    • FIGURE 15 ASIA PACIFIC HELD LARGEST MARKET SHARE IN 2023

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET
    • FIGURE 16 GROWING CONSUMER PREFERENCES FOR NATURAL AND ORGANIC PRODUCTS TO DRIVE DEMAND FOR VITAMIN K2
  • 4.2 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE AND KEY COUNTRY
    • FIGURE 17 MK-7 SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2024
  • 4.3 VITAMIN K2 MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
    • FIGURE 18 US ACCOUNTED FOR LARGEST SHARE IN 2023
  • 4.4 VITAMIN K2 MARKET, BY PRODUCT TYPE AND REGION
    • FIGURE 19 MK-7 SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 VITAMIN K2 MARKET, BY APPLICATION FORM
    • FIGURE 20 POWDER AND CRYSTALLINE SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • 4.6 VITAMIN K2 MARKET, BY SOURCE
    • FIGURE 21 NATURAL SEGMENT TO ACCOUNT FOR LARGER MARKET SIZE DURING FORECAST PERIOD
  • 4.7 VITAMIN K2 MARKET, BY APPLICATION
    • FIGURE 22 HEALTH SUPPLEMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 RISING GDP AND POPULATION
    • FIGURE 23 GLOBAL POPULATION GROWTH, 1950-2050 (BILLION)
    • FIGURE 24 GDP GROWTH, 2016-2023 (USD TRILLION)
    • 5.2.2 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
    • FIGURE 25 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990-2030
    • 5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS
  • 5.3 MARKET DYNAMICS
    • FIGURE 26 VITAMIN K2 MARKET: MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Rising health consciousness among consumers
    • FIGURE 27 OECD HEALTH SPENDING AS SHARE OF GDP, 2017-2021
      • 5.3.1.2 Growing research and development activities
    • FIGURE 28 GLOBAL EXPANSION OF VITAMIN K2 RESEARCH OVER THREE DECADES (1990-2020)
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Inconsistency in regulatory norms
      • 5.3.2.2 Price volatility of raw materials
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Growing demand for natural and plant-based ingredients
      • 5.3.3.2 Rising need for personalized nutrition and customized products
      • 5.3.3.3 Untapped applications
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Lack of consumer awareness regarding specific health benefits
      • 5.3.4.2 High research and development costs

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 SUPPLY CHAIN ANALYSIS
    • FIGURE 29 VITAMIN K2 MARKET: SUPPLY CHAIN ANALYSIS
  • 6.3 VALUE CHAIN ANALYSIS
    • FIGURE 30 VALUE CHAIN ANALYSIS: VITAMIN K2 MARKET
    • 6.3.1 RAW MATERIAL SOURCING
    • 6.3.2 MANUFACTURING AND PROCESSING
      • 6.3.2.1 Product formulation and development
    • 6.3.3 QUALITY ASSURANCE AND CERTIFICATION
    • 6.3.4 MARKETING AND DISTRIBUTION
  • 6.4 TRADE ANALYSIS
    • 6.4.1 EXPORT SCENARIO
    • FIGURE 31 EXPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019-2023 (USD THOUSAND)
    • 6.4.2 IMPORT SCENARIO
    • FIGURE 32 IMPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019-2023 (USD THOUSAND)
    • TABLE 4 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (USD THOUSAND)
    • TABLE 5 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (TON)
    • TABLE 6 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (USD THOUSAND)
    • TABLE 7 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019-2023 (TON)
  • 6.5 TECHNOLOGY ANALYSIS
    • 6.5.1 KEY TECHNOLOGY
      • 6.5.1.1 Fermentation technology
    • 6.5.2 COMPLEMENTARY TECHNOLOGY
      • 6.5.2.1 Encapsulation technology
    • 6.5.3 ADJACENT TECHNOLOGY
      • 6.5.3.1 Biotechnology
  • 6.6 PRICING ANALYSIS
    • 6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE
    • TABLE 8 AVERAGE SELLING PRICE (ASP), BY PRODUCT TYPE, 2020-2023 (USD/TON)
    • FIGURE 33 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2020-2023 (USD/TON)
    • 6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
    • TABLE 9 AVERAGE SELLING PRICE (ASP), BY REGION, 2020-2023 (USD/TON)
  • 6.7 ECOSYSTEM ANALYSIS
    • 6.7.1 DEMAND SIDE
    • 6.7.2 SUPPLY SIDE
    • FIGURE 34 KEY PLAYERS IN VITAMIN K2 ECOSYSTEM
    • TABLE 10 VITAMIN K2 MARKET ECOSYSTEM
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 6.9 PATENT ANALYSIS
    • FIGURE 36 NUMBER OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013-2023
    • FIGURE 37 REGIONAL ANALYSIS OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013-2023
    • 6.9.1 LIST OF MAJOR PATENTS
    • TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO VITAMIN K2, 2020-2023
  • 6.10 KEY CONFERENCES AND EVENTS, 2024-2025
    • TABLE 12 VITAMIN K2 MARKET: KEY DETAILED LIST OF CONFERENCES AND EVENTS, 2024-2025
  • 6.11 REGULATORY LANDSCAPE
    • 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.11.1.1 Regulations in North America
        • 6.11.1.1.1 US
        • 6.11.1.1.2 Canada
      • 6.11.1.2 Regulations in Europe
      • 6.11.1.3 Regulations in Asia Pacific
        • 6.11.1.3.1 China
        • 6.11.1.3.2 India
  • 6.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 16 IMPACT OF PORTER'S FIVE FORCES ON VITAMIN K2 MARKET
    • FIGURE 38 PORTER'S FIVE FORCES ANALYSIS: VITAMIN K2 MARKET
    • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.12.2 BARGAINING POWER OF SUPPLIERS
    • 6.12.3 BARGAINING POWER OF BUYERS
    • 6.12.4 THREAT OF NEW ENTRANTS
    • 6.12.5 THREAT OF SUBSTITUTES
  • 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
    • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
    • 6.13.2 BUYING CRITERIA
    • FIGURE 40 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
    • TABLE 18 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
  • 6.14 CASE STUDY ANALYSIS
    • 6.14.1 ESTABLISHING DISTINCT RECOMMENDED DIETARY INTAKE TO PROMOTE HEALTHIER DIETARY CHOICES
    • 6.14.2 ENHANCING ABILITY IN NUTRACEUTICAL FORMULATIONS FOR IMPROVED QUALITY AND EFFICACY
  • 6.15 INVESTMENT AND FUNDING SCENARIO
    • FIGURE 41 INVESTMENT AND FUNDING SCENARIO, 2019-2024 (USD MILLION)

7 VITAMIN K2 MARKET, BY FUNCTION

  • 7.1 INTRODUCTION
  • 7.2 BONE AND CARDIOVASCULAR HEALTH
    • 7.2.1 COMPREHENSIVE HEALTH BENEFITS TO DRIVE MARKET
  • 7.3 BLOOD HEALTH AND CLOTTING
    • 7.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
  • 7.4 ANTI-INFLAMMATORY AND IMMUNITY
    • 7.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
  • 7.5 OTHER FUNCTIONS

8 VITAMIN K2 MARKET, BY PRODUCT TYPE

  • 8.1 INTRODUCTION
    • TABLE 19 PRODUCT TYPE: OVERVIEW
    • FIGURE 42 MK-7 SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
    • TABLE 20 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 21 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 22 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 23 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
  • 8.2 MK-4
    • 8.2.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET GROWTH
    • TABLE 24 MK-4: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 25 MK-4: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 26 MK-4: VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 27 MK-4: VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)
  • 8.3 MK-7
    • 8.3.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
    • TABLE 28 MK-7: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 29 MK-7: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 30 MK-7: VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 31 MK-7: VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)

9 VITAMIN K2 MARKET, BY APPLICATION FORM

  • 9.1 INTRODUCTION
    • FIGURE 43 POWDER AND CRYSTALLINE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 32 VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 33 VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
  • 9.2 CAPSULES AND TABLETS
    • 9.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
    • TABLE 34 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 35 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.3 POWDER AND CRYSTALLINE
    • 9.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
    • TABLE 36 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 37 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 9.4 LIQUIDS
    • 9.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
    • TABLE 38 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 39 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)

10 VITAMIN K2 MARKET, BY SOURCE

  • 10.1 INTRODUCTION
    • FIGURE 44 NATURAL SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
    • TABLE 40 VITAMIN K2 MARKET: BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 41 VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • 10.2 NATURAL
    • 10.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
    • TABLE 42 NATURAL: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 43 NATURAL: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 10.3 SYNTHETIC
    • 10.3.1 LOW PRODUCTION COST TO DRIVE MARKET
    • TABLE 44 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 45 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)

11 VITAMIN K2 MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 46 APPLICATION: OVERVIEW
    • FIGURE 45 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
    • TABLE 47 VITAMIN K2 MARKET: BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 48 VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.2 PHARMACEUTICALS
    • 11.2.1 RISING GOVERNMENT INVESTMENTS IN DEVELOPMENT OF NEW FORMULATIONS TO DRIVE MARKET
    • TABLE 49 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 50 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 11.3 FUNCTIONAL FOODS AND BEVERAGES
    • 11.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
    • TABLE 51 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 52 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 11.4 HEALTH SUPPLEMENTS
    • 11.4.1 INCREASED AWARENESS REGARDING ASSOCIATED HEALTH BENEFITS TO DRIVE MARKET
    • TABLE 53 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 54 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)

12 VITAMIN K2 MARKET, BY REGION

  • 12.1 INTRODUCTION
    • FIGURE 46 ITALY TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 55 VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 56 VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 57 VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 58 VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)
  • 12.2 NORTH AMERICA
    • TABLE 59 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 60 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 61 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (TON)
    • TABLE 62 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (TON)
    • TABLE 63 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 64 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 65 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 66 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 67 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 68 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 69 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 70 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 71 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 72 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
    • FIGURE 47 INFLATION IN NORTH AMERICA: COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 48 NORTH AMERICA: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.2.2 US
      • 12.2.2.1 Growing awareness regarding importance of preventive health measures to drive market
    • TABLE 73 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 74 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.2.3 CANADA
      • 12.2.3.1 Increasing focus on preventive healthcare and natural products to propel market
    • TABLE 75 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 76 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.2.4 MEXICO
      • 12.2.4.1 High prevalence of chronic lifestyle diseases to drive market
    • TABLE 77 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 78 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
  • 12.3 EUROPE
    • FIGURE 49 EUROPE: VITAMIN K2 MARKET SNAPSHOT
    • TABLE 79 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 80 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 81 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (TON)
    • TABLE 82 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (TON)
    • TABLE 83 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 84 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 85 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 86 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 87 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 88 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 89 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 90 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 91 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 92 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.3.1 EUROPE: RECESSION IMPACT ANALYSIS
    • FIGURE 50 INFLATION IN EUROPE: COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 51 EUROPE: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.3.2 GERMANY
      • 12.3.2.1 Rising focus on proactive healthcare to drive market
    • TABLE 93 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 94 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Innovative products and investments in research and development to boost market growth
    • TABLE 95 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 96 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.4 UK
      • 12.3.4.1 Rapidly aging population to propel market growth
    • TABLE 97 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 98 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.5 ITALY
      • 12.3.5.1 Evolving dietary preferences to boost market growth
    • TABLE 99 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 100 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.6 SPAIN
      • 12.3.6.1 Growing consumer interest in health supplements to propel drive demand
    • TABLE 101 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 102 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.3.7 REST OF EUROPE
    • TABLE 103 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 104 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 52 ASIA PACIFIC VITAMIN K2 MARKET SNAPSHOT
    • TABLE 105 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020-2023 (TON)
    • TABLE 108 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024-2029 (TON)
    • TABLE 109 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 112 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 113 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    • FIGURE 53 INFLATION IN ASIA PACIFIC: COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 54 ASIA PACIFIC: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.4.2 CHINA
      • 12.4.2.1 Surging use of digital media to disseminate healthcare information to propel market
    • TABLE 119 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 120 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.3 JAPAN
      • 12.4.3.1 Consumer preferences for natural healthcare solutions to boost market growth
    • TABLE 121 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 122 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.4 INDIA
      • 12.4.4.1 Strategic market penetration initiatives by various companies to drive market
    • TABLE 123 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 124 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.5 AUSTRALIA AND NEW ZEALAND
      • 12.4.5.1 Changing consumer preferences and increasing health consciousness to drive demand
    • TABLE 125 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 126 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.4.6 REST OF ASIA PACIFIC
    • TABLE 127 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 128 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
  • 12.5 ROW
    • TABLE 129 ROW: VITAMIN K2 MARKET, BY REGION, 2020-2023 (USD MILLION)
    • TABLE 130 ROW: VITAMIN K2 MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 131 ROW: VITAMIN K2 MARKET, BY REGION, 2020-2023 (TON)
    • TABLE 132 ROW: VITAMIN K2 MARKET, BY REGION, 2024-2029 (TON)
    • TABLE 133 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 134 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • TABLE 135 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (TON)
    • TABLE 136 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (TON)
    • TABLE 137 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020-2023 (USD MILLION)
    • TABLE 138 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024-2029 (USD MILLION)
    • TABLE 139 ROW: VITAMIN K2 MARKET, BY SOURCE, 2020-2023 (USD MILLION)
    • TABLE 140 ROW: VITAMIN K2 MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 141 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
    • TABLE 142 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 12.5.1 ROW: RECESSION IMPACT ANALYSIS
    • FIGURE 55 INFLATION IN ROW, COUNTRY-LEVEL DATA, 2017-2022
    • FIGURE 56 ROW: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS
    • 12.5.2 SOUTH AMERICA
      • 12.5.2.1 Collaboration among key market players to drive market growth
    • TABLE 143 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 144 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)
    • 12.5.3 MIDDLE EAST AND AFRICA
      • 12.5.3.1 Developing regulatory landscape to propel market growth
    • TABLE 145 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020-2023 (USD MILLION)
    • TABLE 146 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024-2029 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 147 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS
  • 13.3 REVENUE ANALYSIS
    • FIGURE 57 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST THREE YEARS, 2021-2023 (USD MILLION)
  • 13.4 MARKET SHARE ANALYSIS
    • FIGURE 58 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2023
    • TABLE 148 VITAMIN K2 MARKET: DEGREE OF COMPETITION
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.5.1 COMPANY VALUATION
    • FIGURE 59 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS, 2023 (USD BILLION)
    • 13.5.2 EV/EBITDA
    • FIGURE 60 EV/EBITDA OF KEY COMPANIES, 2023
  • 13.6 BRAND/PRODUCT COMPARISON ANALYSIS
    • FIGURE 61 BRAND/PRODUCT COMPARISON ANALYSIS, BY PRODUCT TYPE
    • 13.6.1 MENAQUINGOLD
    • 13.6.2 MENAQ7
    • 13.6.3 K2VITAL
    • 13.6.4 VITAMK7
    • 13.6.5 MENATTO
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • FIGURE 62 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.7.5.1 Company footprint
    • FIGURE 63 VITAMIN K2 MARKET: COMPANY FOOTPRINT
      • 13.7.5.2 Regional footprint
    • TABLE 149 VITAMIN K2 MARKET: REGIONAL FOOTPRINT
      • 13.7.5.3 Product type footprint
    • TABLE 150 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
      • 13.7.5.4 Application footprint
    • TABLE 151 VITAMIN K2 MARKET: APPLICATION FOOTPRINT
      • 13.7.5.5 Source footprint
    • TABLE 152 VITAMIN K2 MARKET: SOURCE FOOTPRINT
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • FIGURE 64 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 13.8.5 COMPETITIVE BENCHMARKING
      • 13.8.5.1 Detailed list of key startups/SMEs
    • TABLE 153 VITAMIN K2 MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2023
      • 13.8.5.2 Competitive benchmarking of key startup/SMEs
    • TABLE 154 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
  • 13.9 COMPETITIVE SCENARIO AND TRENDS
    • 13.9.1 PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 155 VITAMIN K2 MARKET: PRODUCT LAUNCHES AND DEVELOPMENTS, JANUARY 2020-JUNE 2024
    • 13.9.2 DEALS
    • TABLE 156 VITAMIN K2 MARKET: DEALS, JANUARY 2020-JUNE 2024
    • 13.9.3 EXPANSIONS
    • TABLE 157 VITAMIN K2 MARKET: EXPANSIONS, JANUARY 2020-JUNE 2024
    • 13.9.4 OTHERS
    • TABLE 158 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, JANUARY 2020 - JUNE 2024

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats)**
    • 14.1.1 GNOSIS BY LESAFFRE (NATTOPHARMA)
    • TABLE 159 GNOSIS BY LESAFFRE (NATTOPHARMA): COMPANY OVERVIEW
    • TABLE 160 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 161 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 162 GNOSIS BY LESAFFRE (NATTOPHARMA): DEALS
    • TABLE 163 GNOSIS BY LESAFFRE (NATTOPHARMA): OTHER DEALS/DEVELOPMENTS
    • 14.1.2 KAPPA BIOSCIENCE AS (BALCHEM CORP.)
    • TABLE 164 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY OVERVIEW
    • FIGURE 65 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY SNAPSHOT
    • TABLE 165 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 166 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 167 KAPPA BIOSCIENCE AS (BALCHEM CORP.): DEALS
    • TABLE 168 KAPPA BIOSCIENCE AS (BALCHEM CORP.): EXPANSIONS
    • TABLE 169 KAPPA BIOSCIENCE AS (BALCHEM CORP.): OTHER DEALS/DEVELOPMENTS
    • 14.1.3 J-OIL MILLS, INC.
    • TABLE 170 J-OIL MILLS, INC.: COMPANY OVERVIEW
    • FIGURE 66 J-OIL MILLS, INC.: COMPANY SNAPSHOT
    • TABLE 171 J-OIL MILLS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 172 J-OIL MILLS, INC.: PRODUCT LAUNCHES AND DEVELOPMENTS
    • TABLE 173 J-OIL MILLS, INC.: DEALS
    • 14.1.4 NOVOZYMES A/S
    • TABLE 174 NOVOZYMES A/S: COMPANY OVERVIEW
    • FIGURE 67 NOVOZYMES A/S: COMPANY SNAPSHOT
    • TABLE 175 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 176 NOVOZYMES A/S: DEALS
    • 14.1.5 BASF SE
    • TABLE 177 BASF SE: COMPANY OVERVIEW
    • FIGURE 68 BASF SE: COMPANY SNAPSHOT
    • TABLE 178 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.6 SUNGEN BIOSCIENCE CO.,LTD
    • TABLE 179 SUNGEN BIOSCIENCE CO.,LTD: COMPANY OVERVIEW
    • TABLE 180 SUNGEN BIOSCIENCE CO.,LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.7 VESTA NUTRA
    • TABLE 181 VESTA NUTRA: COMPANY OVERVIEW
    • TABLE 182 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.8 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
    • TABLE 183 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • TABLE 184 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 185 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
    • 14.1.9 MENADIONA
    • TABLE 186 MENADIONA: COMPANY OVERVIEW
    • TABLE 187 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 188 MENADIONA: PRODUCT LAUNCHES AND DEVELOPMENTS
    • 14.1.10 GENOFOCUS
    • TABLE 189 GENOFOCUS: COMPANY OVERVIEW
    • TABLE 190 GENOFOCUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 191 GENOFOCUS: PRODUCT LAUNCHES AND DEVELOPMENTS
    • 14.1.11 ANGELYEAST CO., LTD.
    • TABLE 192 ANGELYEAST CO., LTD.: COMPANY OVERVIEW
    • TABLE 193 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.12 GENEFERM BIOTECHNOLOGY CO., LTD.
    • TABLE 194 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • TABLE 195 GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.13 NAKODA CHEMICALS LTD.
    • TABLE 196 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
    • TABLE 197 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.14 HAIHANG INDUSTRY
    • TABLE 198 HAIHANG INDUSTRY: COMPANY OVERVIEW
    • TABLE 199 HAIHANG INDUSTRY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.15 CHEMICEA LIMITED
    • TABLE 200 CHEMICEA LIMITED: COMPANY OVERVIEW
    • TABLE 201 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.16 KYOWA HAKKO U.S.A., INC.
    • TABLE 202 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
    • TABLE 203 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 14.2 STARTUPS/SMES
    • 14.2.1 SEEBIO BIOTECH (SHANGHAI) CO.,LTD.
    • TABLE 204 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
    • 14.2.2 MAGNESIA GMBH
    • TABLE 205 MAGNESIA GMBH: COMPANY OVERVIEW
    • 14.2.3 FALCON TRADING INTERNATIONAL
    • TABLE 206 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
    • 14.2.4 ABCO INDIA
    • TABLE 207 ABCO INDIA: COMPANY OVERVIEW
    • 14.2.5 ACT
    • TABLE 208 ACT: COMPANY OVERVIEW
  • *Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

15 ADJACENT AND RELATED MARKETS

  • 15.1 INTRODUCTION
    • TABLE 209 ADJACENT MARKETS TO VITAMIN K2 MARKET
  • 15.2 LIMITATIONS
  • 15.3 DIETARY SUPPLEMENTS MARKET
    • 15.3.1 MARKET DEFINITION
    • 15.3.2 MARKET OVERVIEW
    • TABLE 210 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 211 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 15.4 VITAMINS MARKET
    • 15.4.1 MARKET DEFINITION
    • 15.4.2 MARKET OVERVIEW
    • TABLE 212 VITAMINS MARKET, BY REGION, 2017-2022 (USD MILLION)
    • TABLE 213 VITAMINS MARKET, BY REGION, 2023-2028 (USD MILLION)

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS